Pricing Log in Create free account

Apollomics Inc. (APLM) vs Fortress Biotech, Inc. (FBIO)

Apollomics Inc. and Fortress Biotech, Inc. are both Biotechnology companies. Apollomics Inc. and Fortress Biotech, Inc. are of similar size ($63.7M and $61.2M). Apollomics Inc. has negative trailing earnings, so its P/E is not meaningful; Fortress Biotech, Inc. trades at 0.6×. Fortress Biotech, Inc. has the higher net margin (151.0% vs 0.00%) and the lower return on invested capital (−41.3% vs 0.00%). Across the 12 metrics below, Fortress Biotech, Inc. leads on 8 and Apollomics Inc. on 4.

Valuation

Metric APLM FBIO Biotechnology median
P/E n/m 0.57 8.50
P/S n/m 0.87 9.71
P/B n/m 0.29 2.13
Price to free cash flow n/m 0.69 20.82
EV/EBITDA n/m 4.86 0.64
EV/Sales n/m (1.44) 9.21
Earnings yield (0.28%) 174.33% (33.15%)
Free cash flow yield 0.00% 144.39% (25.50%)

Profitability

Metric APLM FBIO Biotechnology median
Gross margin — 65.59% 65.16%
Operating margin — (42.61%) 0.00%
Net margin 0.00% 150.98% 0.00%
Free cash flow margin 0.00% 183.80% 0.00%
Return on equity 0.00% 84.91% (56.36%)
Return on assets 0.00% 43.38% (48.04%)
Return on invested capital 0.00% (41.34%) 0.00%

Growth

Metric APLM FBIO Biotechnology median
Revenue growth (TTM) — 15.46% 6.02%
EPS growth (last fiscal year) 85.66% 97.40% 30.26%
Revenue growth, 5-year CAGR 32.77% 6.77% 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric APLM FBIO Biotechnology median
Debt to equity 0.00 0.17 0.00
Current ratio 0.96 3.96 4.72
Net debt to EBITDA 0.37 0.43 0.96

Dividend

Metric APLM FBIO Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric APLM FBIO Biotechnology median
Market cap 61.22m 63.70m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack